Back to the main directory
EarningsReview / Equity
- Q318 postview (+15 questions for management) by BNP Paribas Exane
- Investment Daily 13/11/2018 by BNP Paribas Exane
- Sandvik (Buy, TP: SEK190.00) - Slightly lower SMS forecast for Q4 by DnB Markets
- WOOD Flash – Play Communications: 3Q18 results in line, 2018E guidance maintained, mid-term guidance vague by Wood and Company
- BerGenBio (Buy, TP: NOK56.00) - Still early, but pipeline maturing by DnB Markets
- Ambea (Hold, TP: SEK88.00) - Solid, awaiting Aleris addition by DnB Markets
- SATS: Reiterate Strong Buy as Hughes Continues to Grow and Stock Buybacks Begin by Raymond James
- FOCS: 3Q18 Recap: Disappointing Organic Revenue Growth, TP to $39 by Raymond James
- Q3 18 postview by BNP Paribas Exane
- PRAA: Allowance Charges from 2015 Consent Order Still a Problem; Reit. MP3 by Raymond James
- Frontline (Buy, TP: NOK60.00) - BUY ahead of Q3 results by DnB Markets
- QRVO: The Domino Effect - Qorvo Lowers Outlook on Apple Cuts by Raymond James
- AAP: Slight Adjustments to Sales/Earnings Outlook by Raymond James
- CLNC: Maintain Outperform Rating After in-Line 3Q Adjusted Core EPS by Raymond James
- CRD.B: Consolidated Results to Improve in 2019; Maintain Outperform by Raymond James
- MTSI: Finding Stability, 5G on the Come by Raymond James
- PETQ: 3Q Results Reflect Continued Top Line Momentum, Tweaking Target by Raymond James
- NINE: Completions Margins March Forward; Maintaining Bullish Outlook by Raymond James
- Surprise! by BNP Paribas Exane
- Weak Q3, but positive outlook on Q4 and 2019 by BNP Paribas Exane
- WIX: Modest 3Q Revenue Upside and Solid Leverage; Maintain Outperform & $115 PT by Raymond James
- Growth trumps earnings by BNP Paribas Exane
- Simply organic by BNP Paribas Exane
- Iliad: Signs of Recovery in Q3; Solid 2019 Outlook Assuming a Nice New Box (TP to €190) by Raymond James
- Tecnicas Reunidas: Q3'18 Recap: Miss Driven by Slow EBIT Margin Recovery; Cutting 2018-20 Estimates by Raymond James